Clinical Trial Update: Efficacy and Safety of Imatinib in Chordoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Imatinib for chordoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chordoma | Phase 2 | Status: COMPLETED